This is the most common cancer type, accounting for about half of all pediatric cancer cases. These are divided into 2 types:
– Acute Lymphoblastic Leukemia (ALL), which is 3 times more common than AML
– Acute Myeloid Leukemia (AML)
The Most Common Symptoms are fever, pallor, and bruising or bleeding throughout the body. There may also be enlargement of the liver and spleen, pain throughout the body, swelling lymph nodes, and enlargement of either one or both testicles in males, and immature white blood cells found during complete blood counts (CBC).
Diagnosis of both ALL and AML is carried out by examining the child’s bone marrow for the types and abnormalities of white blood cells present. Additionally, a cerebrospinal fluid (CSF) analysis can be carried out to determine the spread of leukemia cells, which is important for treatment planning and prognosis.
Treatment of Acute Leukemia is currently carried out using chemotherapy, given in consecutive phases over a long period of time, depending on the type of leukemia. Treatment for ALL usually takes about 2.5-3 years, while AML treatment takes about 6 months. For patients in whom the disease is at an advanced stage or in whom it is recurrent, a bone marrow transplant is the next step. Today, patients no longer need to delay transplantation by waiting for a perfect or near-perfect match. Instead, one of their parents can be the bone marrow donor. This is known as Haploidentical Hematopoietic Stem Cell Transplantation. You can read more about this new, state-of-the-art treatment here
Currently the treatment success rate for ALL is excellent, at 80-85%, while AML has a 55% treatment success rate. The survival rate of AML for patients treated with chemotherapy is 50%, however this increases to 80% if patients were treated with bone marrow transplant from the beginning.